We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+14.7%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$26.8B
AUM Growth
+$2.91B
(+12%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
30.26%
Holding
2,338
New
416
Increased
946
Reduced
559
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$80.5M |
| 2 |
Netflix
NFLX
|
+$48M |
| 3 |
Broadcom
AVGO
|
+$47.1M |
| 4 |
Palantir
PLTR
|
+$44.5M |
| 5 |
Intuitive Surgical
ISRG
|
+$41.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$62.2M |
| 2 |
Global Payments
GPN
|
+$50.1M |
| 3 |
Honeywell
HON
|
+$31.1M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$30.5M |
| 5 |
Medtronic
MDT
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.25% |
| 2 | Financials | 14.66% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Communication Services | 9.36% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Mineralys Therapeutics
MLYS
$2.35B
| $208K | ﹤0.01% |
15,400
-7,200
| -32% | -$104K |
|
|
DVAX
1652
DELISTED
Dynavax Technologies
DVAX
| $206K | ﹤0.01% |
20,800
+1,500
| +8% | +$15.8K |
|
|
TWO
1653
Two Harbors Investment
TWO
$1.27B
| $206K | ﹤0.01% |
19,100
| – | – |
|
1654
Asana
ASAN
$1.58B
| $205K | ﹤0.01% |
15,200
+1,800
| +13% | +$28.2K |
|
1655
JELD-WEN Holding
JELD
$94.8M
| $204K | ﹤0.01% |
52,100
+3,700
| +8% | +$16.5K |
|
1656
Empire State Realty Trust
ESRT
$976M
| $203K | ﹤0.01% |
25,100
| – | – |
|
1657
Bentley Systems
BSY
$9.54B
| $203K | ﹤0.01% |
+3,762
| New | +$174K |
|
|
UCB
1658
United Community Banks
UCB
$4.22B
| $203K | ﹤0.01% |
6,800
+500
| +8% | +$13.9K |
|
1659
CAVA Group
CAVA
$7.22B
| $201K | ﹤0.01% |
2,385
-6,479
| -73% | -$553K |
|
1660
Alta Equipment Group
ALTG
$210M
| $200K | ﹤0.01% |
31,700
+2,200
| +7% | +$11.1K |
|
1661
Denali Therapeutics
DNLI
$3.67B
| $200K | ﹤0.01% |
14,300
-9,500
| -40% | -$134K |
|
1662
BV Financial
BVFL
$177M
| $200K | ﹤0.01% |
+13,100
| New | +$197K |
|
|
TSSI
1663
TSS Inc
TSSI
$272M
| $199K | ﹤0.01% |
+6,900
| New | +$90.7K |
|
1664
Donaldson
DCI
$10.8B
| $197K | ﹤0.01% |
+2,847
| New | +$191K |
|
1665
Vestis
VSTS
$2.06B
| $197K | ﹤0.01% |
+34,400
| New | +$241K |
|
1666
Riley Exploration Permian
REPX
$770M
| $197K | ﹤0.01% |
7,500
+600
| +9% | +$15.8K |
|
1667
Bassett Furniture
BSET
$169M
| $196K | ﹤0.01% |
+12,900
| New | +$213K |
|
1668
STAAR Surgical
STAA
$1.16B
| $195K | ﹤0.01% |
11,600
+800
| +7% | +$14.1K |
|
1669
MarketAxess Holdings
MKTX
$4.15B
| $195K | ﹤0.01% |
+871
| New | +$191K |
|
1670
Advanced Drainage Systems
WMS
$10.9B
| $194K | ﹤0.01% |
+1,689
| New | +$189K |
|
|
AAT
1671
American Assets Trust
AAT
$1.49B
| $194K | ﹤0.01% |
9,800
+1,100
| +13% | +$21.4K |
|
1672
Floor & Decor
FND
$5.81B
| $193K | ﹤0.01% |
+2,544
| New | +$189K |
|
|
UNIT
1673
Uniti Group
UNIT
$2.63B
| $193K | ﹤0.01% |
44,700
| – | – |
|
1674
Bio-Techne
TECH
$11.2B
| $193K | ﹤0.01% |
+3,748
| New | +$188K |
|
1675
Molson Coors Class B
TAP
$7.68B
| $193K | ﹤0.01% |
+4,009
| New | +$221K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2025 Portfolio in Review
As of Q2 2025, STRS Ohio held 2,338 positions worth $26.8B, up 12% from $23.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
STRS Ohio's Q2 2025 filing shows 416 new, 946 increased, 559 reduced and 143 closed positions. Its largest new stake was Rockwell Automation: 97,205 shares worth $32.3M. The largest sale was Progressive, an estimated $62.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- STRS Ohio's largest Q2 2025 buy was Rockwell Automation: 97,205 shares worth $32.3M.
- STRS Ohio added most to Microsoft in Q2 2025, an estimated $80.5M increase.
- STRS Ohio's biggest Q2 2025 reduction was Progressive, cutting an estimated $62.2M.
- STRS Ohio fully exited AstraZeneca in Q2 2025, selling an estimated $26.8M.
- STRS Ohio's ten largest holdings make up 30% of its $26.8B portfolio in Q2 2025.
- STRS Ohio opened 416 new positions and closed 143 in Q2 2025.
- STRS Ohio's portfolio value rose 12% quarter-over-quarter to $26.8B.
Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.